Multi-objective generative AI for designing novel brain-targeting small molecules
- URL: http://arxiv.org/abs/2407.00004v1
- Date: Tue, 16 Apr 2024 12:57:06 GMT
- Title: Multi-objective generative AI for designing novel brain-targeting small molecules
- Authors: Ayush Noori, IƱaki Arango, William E. Byrd, Nada Amin,
- Abstract summary: We use multi-objective generative AI to synthesize drug-like BBB-permeable small molecules.
Specifically, we computationally synthesize molecules with predicted binding affinity against dopamine receptor D2.
We design a library of 26,581 novel and diverse small molecules containing hits with high predicted BBB permeability and favorable predicted safety and toxicity profiles.
- Score: 0.20088541799100385
- License: http://creativecommons.org/licenses/by-sa/4.0/
- Abstract: The strict selectivity of the blood-brain barrier (BBB) represents one of the most formidable challenges to successful central nervous system (CNS) drug delivery. Computational methods to generate BBB permeable drugs in silico may be valuable tools in the CNS drug design pipeline. However, in real-world applications, BBB penetration alone is insufficient; rather, after transiting the BBB, molecules must bind to a specific target or receptor in the brain and must also be safe and non-toxic. To discover small molecules that concurrently satisfy these constraints, we use multi-objective generative AI to synthesize drug-like BBB-permeable small molecules. Specifically, we computationally synthesize molecules with predicted binding affinity against dopamine receptor D2, the primary target for many clinically effective antipsychotic drugs. After training several graph neural network-based property predictors, we adapt SyntheMol (Swanson et al., 2024), a recently developed Monte Carlo Tree Search-based algorithm for antibiotic design, to perform a multi-objective guided traversal over an easily synthesizable molecular space. We design a library of 26,581 novel and diverse small molecules containing hits with high predicted BBB permeability and favorable predicted safety and toxicity profiles, and that could readily be synthesized for experimental validation in the wet lab. We also validate top scoring molecules with molecular docking simulation against the D2 receptor and demonstrate predicted binding affinity on par with risperidone, a clinically prescribed D2-targeting antipsychotic. In the future, the SyntheMol-based computational approach described here may enable the discovery of novel neurotherapeutics for currently intractable disorders of the CNS.
Related papers
- Regressor-free Molecule Generation to Support Drug Response Prediction [83.25894107956735]
Conditional generation based on the target IC50 score can obtain a more effective sampling space.
Regressor-free guidance combines a diffusion model's score estimation with a regression controller model's gradient based on number labels.
arXiv Detail & Related papers (2024-05-23T13:22:17Z) - Quantum Computing-Enhanced Algorithm Unveils Novel Inhibitors for KRAS [10.732020360180773]
We introduce a quantum-classical generative model that seamlessly integrates the power of quantum algorithms trained on a 16-qubit IBM quantum computer.
Our work shows for the first time the use of a quantum-generative model to yield experimentally confirmed biological hits.
arXiv Detail & Related papers (2024-02-13T04:19:06Z) - LIMO: Latent Inceptionism for Targeted Molecule Generation [14.391216237573369]
We present Latent Inceptionism on Molecules (LIMO), which significantly accelerates molecule generation with an inceptionism-like technique.
Comprehensive experiments show that LIMO performs competitively on benchmark tasks.
One of our generated drug-like compounds has a predicted $K_D$ of $6 cdot 10-14$ M against the human estrogen receptor.
arXiv Detail & Related papers (2022-06-17T21:05:58Z) - Exploring Chemical Space with Score-based Out-of-distribution Generation [57.15855198512551]
We propose a score-based diffusion scheme that incorporates out-of-distribution control in the generative differential equation (SDE)
Since some novel molecules may not meet the basic requirements of real-world drugs, MOOD performs conditional generation by utilizing the gradients from a property predictor.
We experimentally validate that MOOD is able to explore the chemical space beyond the training distribution, generating molecules that outscore ones found with existing methods, and even the top 0.01% of the original training pool.
arXiv Detail & Related papers (2022-06-06T06:17:11Z) - Accelerating Inhibitor Discovery for Multiple SARS-CoV-2 Targets with a
Single, Sequence-Guided Deep Generative Framework [47.14853881703749]
We demonstrate the broad utility of a single deep generative framework toward discovering novel drug-like inhibitor molecules.
To perform target-aware design, the framework employs a target sequence-conditioned sampling of novel molecules from a generative model.
The most potent spike RBD inhibitor also emerged as a rare non-covalent antiviral with broad-spectrum activity against several SARS-CoV-2 variants.
arXiv Detail & Related papers (2022-04-19T17:59:46Z) - Hybrid quantum-classical machine learning for generative chemistry and
drug design [0.0]
We build a compact discrete variational autoencoder with a Boltzmann Machine (RBM) of reduced size in its latent layer.
We generate 2331 novel chemical structures with medicinal chemistry and synthetic accessibility properties.
Results demonstrate the feasibility of using already existing or soon-to-be-available quantum computing devices as testbeds for future drug discovery applications.
arXiv Detail & Related papers (2021-08-26T08:23:32Z) - MIMOSA: Multi-constraint Molecule Sampling for Molecule Optimization [51.00815310242277]
generative models and reinforcement learning approaches made initial success, but still face difficulties in simultaneously optimizing multiple drug properties.
We propose the MultI-constraint MOlecule SAmpling (MIMOSA) approach, a sampling framework to use input molecule as an initial guess and sample molecules from the target distribution.
arXiv Detail & Related papers (2020-10-05T20:18:42Z) - Accelerating Antimicrobial Discovery with Controllable Deep Generative
Models and Molecular Dynamics [109.70543391923344]
CLaSS (Controlled Latent attribute Space Sampling) is an efficient computational method for attribute-controlled generation of molecules.
We screen the generated molecules for additional key attributes by using deep learning classifiers in conjunction with novel features derived from atomistic simulations.
The proposed approach is demonstrated for designing non-toxic antimicrobial peptides (AMPs) with strong broad-spectrum potency.
arXiv Detail & Related papers (2020-05-22T15:57:58Z) - CogMol: Target-Specific and Selective Drug Design for COVID-19 Using
Deep Generative Models [74.58583689523999]
We propose an end-to-end framework, named CogMol, for designing new drug-like small molecules targeting novel viral proteins.
CogMol combines adaptive pre-training of a molecular SMILES Variational Autoencoder (VAE) and an efficient multi-attribute controlled sampling scheme.
CogMol handles multi-constraint design of synthesizable, low-toxic, drug-like molecules with high target specificity and selectivity.
arXiv Detail & Related papers (2020-04-02T18:17:20Z) - Application and Assessment of Deep Learning for the Generation of
Potential NMDA Receptor Antagonists [0.0]
Uncompetitive antagonists of the N-methyl D-aspartate receptor (NMDAR) have demonstrated therapeutic benefit in the treatment of neurological diseases such as Parkinson's and Alzheimer's.
Some also cause dissociative effects that have led to the synthesis of illicit drugs.
The ability to generate NMDAR antagonists in silico is therefore desirable both for new medication development and for preempting and identifying new designer drugs.
arXiv Detail & Related papers (2020-03-31T16:41:18Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.